- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Wyden Backs Effort to Repeal Doc-Pay Formula, Offers No Plan to Pay for It
Sen. Ron Wyden (D-Ore.), in his first speech as the new chairman of the powerful Senate Finance Committee, said it's important for Congress to pass legislation that would permanently repeal Medicare's contentious physician payment formula, but did not say how lawmakers intend to pay for it.
Sen. Ron Wyden (D-Ore.), in his first speech as the new chairman of the powerful Senate Finance Committee, said it's important for Congress to pass legislation that would permanently repeal Medicare's contentious physician payment formula, but did not say how lawmakers intend to pay for it.
Finding a way to pay for the legislation continues to be the biggest challenge for lawmakers and could thwart their efforts for approving a permanent solution this year. Wyden didn't comment on the possibility of another temporary SGR fix if the funding puzzle can't be solved.
The Oregon Democrat and successor to former Sen. Max Baucus (D-Mont.) began his remarks at the Federation of American Hospitals' annual conference in Washington by noting that Congress has an opportunity to move beyond lurching from one budget crisis to another with the permanent SGR bill that lawmakers are currently considering.
Read the full story here: http://bit.ly/1kyVEvT
Source: Modern Healthcare
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars
November 21st 2023Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
Therapists’ Perspectives on Access to Telemental Health Among Medicaid-Enrolled Youth
November 10th 2023This qualitative study elucidates therapists’ perspectives on barriers to and facilitators of access to telemental health among Medicaid-enrolled youth served by a large safety-net organization.
Read More
